In addition, the analysis of ERAS expression data from TCGA also suggests that a low percentage of breast tumors express ERAS, and immunohistochemical analysis of a grade 3 breast tumor tissue microarray confirmed that ERAS is aberrantly expressed in less than 10% of tumors. The gene discussed is ERAS; the disease is breast neoplasm.